Works matching DE "MARAVIROC (Drug)"

Results: 186
    1

    Blocking CCR5.

    Published in:
    Nature Structural & Molecular Biology, 2013, v. 20, n. 10, p. 1145, doi. 10.1038/nsmb.2693
    By:
    • Chen, Inês
    Publication type:
    Article
    2
    3
    4
    5

    No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV‐1–Infected Subjects.

    Published in:
    Journal of Clinical Pharmacology, 2019, v. 59, n. 1, p. 139, doi. 10.1002/jcph.1306
    By:
    • Vourvahis, Manoli;
    • Smith, Kimberly Y.;
    • Heera, Jayvant;
    • McFadyen, Lynn;
    • Chan, Phylinda L. S.;
    • Nepal, Sunil;
    • Valluri, Srinivas Rao;
    • Fang, Annie;
    • Fate, Gwendolyn D.;
    • Wood, Linda S.;
    • Marshall, Jean‐Claude;
    • Nedderman, Angus;
    • Haynes, Julian;
    • Savage, Mark E.;
    • Clark, Andrew
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Maraviroc/raltegravir simplification strategy following 6 months of quadruple therapy with tenofovir/emtricitabine/maraviroc/raltegravir in treatment-naive HIV patients.

    Published in:
    2016
    By:
    • Pradat, Pierre;
    • Durant, Jacques;
    • Brochier, Corinne;
    • Trabaud, Mary-Anne;
    • Cottalorda-Dufayard, Jacqueline;
    • Izopet, Jacques;
    • Raffi, François;
    • Gatey, Caroline;
    • Jacomet, Christine;
    • Vassallo, Matteo;
    • Dellamonica, Pierre;
    • Cotte, Laurent;
    • Lucht, Frédéric;
    • Gagnieu, Marie-Claude;
    • No Nuc No Boost Study Group
    Publication type:
    journal article
    12
    13
    14
    15
    16

    Virological failure of patients on maraviroc-based antiretroviral therapy.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 6, p. 1858, doi. 10.1093/jac/dkv026
    By:
    • Raymond, Stéphanie;
    • Maillard, Anne;
    • Amiel, Corinne;
    • Peytavin, Gilles;
    • Trabaud, Mary Anne;
    • Desbois, Delphine;
    • Bellecave, Pantxika;
    • Delaugerre, Constance;
    • Soulie, Cathia;
    • Marcelin, Anne Geneviève;
    • Descamps, Diane;
    • Izopet, Jacques
    Publication type:
    Article
    17
    18
    19
    20
    21

    Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 6, p. 1648
    By:
    • Katlama, Christine;
    • Assoumou, Lambert;
    • Valantin, Marc-Antoine;
    • Soulié, Cathia;
    • Duvivier, Claudine;
    • Chablais, Laetitia;
    • Kolta, Sami;
    • Pialoux, Gilles;
    • Mercié, Patrick;
    • Simon, Anne;
    • Costagliola, Dominique;
    • Peytavin, Gilles;
    • Marcelin, Anne-Genevieve
    Publication type:
    Article
    22
    23

    Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 3, p. 735
    By:
    • Meini, Genny;
    • Rossetti, Barbara;
    • Bianco, Claudia;
    • Ceccherini-Silberstein, Francesca;
    • Di Giambenedetto, Simona;
    • Sighinolfi, Laura;
    • Monno, Laura;
    • Castagna, Antonella;
    • Rozera, Gabriella;
    • D'Arminio Monforte, Antonella;
    • Zazzi, Maurizio;
    • De Luca, Andrea
    Publication type:
    Article
    24

    Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 12, p. 2882, doi. 10.1093/jac/dkt272
    By:
    • Todesco, Eve;
    • Sayon, Sophie;
    • Fourati, Slim;
    • Tubiana, Roland;
    • Simon, Anne;
    • Ktorza, Nadine;
    • Schneider, Luminita;
    • Peytavin, Gilles;
    • Malet, Isabelle;
    • Van den Eede, Peter;
    • Katlama, Christine;
    • Calvez, Vincent;
    • Marcelin, Anne-Genevieve;
    • Wirden, Marc
    Publication type:
    Article
    25
    26
    27
    28
    29

    Immune recovery and T cell subset analysis during effective treatment with maraviroc.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 10, p. 2474, doi. 10.1093/jac/dks216
    By:
    • Cossarini, Francesca;
    • Galli, Andrea;
    • Galli, Laura;
    • Bigoloni, Alba;
    • Salpietro, Stefania;
    • Vinci, Concetta;
    • Della Torre, Liviana;
    • Gianotti, Nicola;
    • Spagnuolo, Vincenzo;
    • Lazzarin, Adriano;
    • Castagna, Antonella;
    • Nozza, Silvia
    Publication type:
    Article
    30

    Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 6, p. 1479, doi. 10.1093/jac/dks055
    By:
    • Baroncelli, Silvia;
    • Galluzzo, Clementina Maria;
    • Weimer, Liliana Elena;
    • Pirillo, Maria Franca;
    • Volpe, Anna;
    • Mercuri, Alessandra;
    • Cavalli, Albertina;
    • Fragola, Vincenzo;
    • Monno, Laura;
    • Degli Antoni, Anna;
    • Ladisa, Nicoletta;
    • Francisci, Daniela;
    • Bucciardini, Raffaella;
    • Floridia, Marco
    Publication type:
    Article
    31
    32
    33
    34
    35

    Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 2, p. 265, doi. 10.1093/jac/dkq458
    By:
    • Vandekerckhove, Linos;
    • Verhofstede, Chris;
    • Demecheleer, Els;
    • De Wit, Stephane;
    • Florence, Eric;
    • Fransen, Katrien;
    • Moutschen, Michel;
    • Mostmans, Wendy;
    • Kabeya, Kabamba;
    • Mackie, Nicola;
    • Plum, Jean;
    • Vaira, Dolores;
    • Baelen, Kurt Van;
    • Vandenbroucke, Ina;
    • Eygen, Veerle Van;
    • Marck, Herwig Van;
    • Vogelaers, Dirk;
    • Geretti, Anna Maria;
    • Stuyver, Lieven J.
    Publication type:
    Article
    36
    37
    38
    39

    Network meta‐analysis of post‐exposure prophylaxis randomized clinical trials.

    Published in:
    HIV Medicine, 2021, v. 22, n. 3, p. 218, doi. 10.1111/hiv.12964
    By:
    • Fernández, I;
    • Lazzari, E.;
    • Inciarte, A.;
    • Diaz‐Brito, V.;
    • Milinkovic, A.;
    • Arenas‐Pinto, A.;
    • Etcheverrry, F.;
    • García, F.;
    • Leal, L;
    • Fernandez, E;
    • Gonzalez, E;
    • Lucero, C;
    • Leon, A;
    • Garcıa, F;
    • Manzardo, C;
    • Nicolas, D;
    • Bodro, M;
    • del Rıo, A;
    • Cardozo, C;
    • Cervera, C
    Publication type:
    Article
    40

    Week 96 results of the randomized, multicentre Maraviroc Switch ( MARCH) study.

    Published in:
    HIV Medicine, 2018, v. 19, n. 1, p. 65, doi. 10.1111/hiv.12532
    By:
    • Pett, S. L.;
    • Amin, J.;
    • Horban, A.;
    • Andrade‐Villanueva, J.;
    • Losso, M.;
    • Porteiro, N.;
    • Madero, J. S.;
    • Belloso, W.;
    • Tu, E.;
    • Silk, D.;
    • Kelleher, A.;
    • Harrigan, R.;
    • Clark, A.;
    • Sugiura, W.;
    • Wolff, M.;
    • Gill, J.;
    • Gatell, J.;
    • Clarke, A.;
    • Ruxrungtham, K.;
    • Prazuck, T.
    Publication type:
    Article
    41

    Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.

    Published in:
    HIV Medicine, 2017, v. 18, n. 7, p. 482, doi. 10.1111/hiv.12479
    By:
    • Poveda, E;
    • Hernández‐Quero, J;
    • Pérez‐Elías, MJ;
    • Ribas, MA;
    • Martínez‐Madrid, OJ;
    • Flores, J;
    • Navarro, J;
    • Gutiérrez, F;
    • García‐Deltoro, M;
    • Imaz, A;
    • Ocampo, A;
    • Artero, A;
    • Blanco, F;
    • Bernal, E;
    • Pasquau, J;
    • Mínguez‐Gallego, C;
    • Pérez, N;
    • Aiestaran, A;
    • García, F;
    • Paredes, R
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48

    Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND)

    Published in:
    Journal of NeuroVirology, 2014, v. 20, n. 6, p. 571, doi. 10.1007/s13365-014-0279-x
    By:
    • Ndhlovu, Lishomwa;
    • Umaki, Tracie;
    • Chew, Glen;
    • Chow, Dominic;
    • Agsalda, Melissa;
    • Kallianpur, Kalpana;
    • Paul, Robert;
    • Zhang, Guangxiang;
    • Ho, Erika;
    • Hanks, Nancy;
    • Nakamoto, Beau;
    • Shiramizu, Bruce;
    • Shikuma, Cecilia
    Publication type:
    Article
    49
    50